Brian Abrahams
Stock Analyst at RBC Capital
(2.24)
# 2,800
Out of 5,040 analysts
439
Total ratings
42.68%
Success rate
-3.56%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GLPG Galapagos NV | Maintains: Sector Perform | $27 → $28 | $32.60 | -14.11% | 12 | Oct 22, 2025 | |
| MLTX MoonLake Immunotherapeutics | Downgrades: Sector Perform | $67 → $10 | $9.34 | +7.07% | 3 | Sep 29, 2025 | |
| APGE Apogee Therapeutics | Initiates: Outperform | $60 | $53.35 | +12.46% | 1 | Sep 25, 2025 | |
| INCY Incyte | Maintains: Sector Perform | $72 → $81 | $88.00 | -7.95% | 23 | Sep 24, 2025 | |
| ATYR aTyr Pharma | Downgrades: Sector Perform | $16 → $1.5 | $0.97 | +54.80% | 1 | Sep 16, 2025 | |
| KYMR Kymera Therapeutics | Initiates: Outperform | $70 | $55.98 | +25.04% | 1 | Sep 16, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Outperform | $144 → $149 | $142.64 | +4.46% | 22 | Sep 5, 2025 | |
| SION Sionna Therapeutics | Initiates: Sector Perform | $22 | $39.51 | -44.32% | 1 | Sep 3, 2025 | |
| XENE Xenon Pharmaceuticals | Reiterates: Outperform | $55 | $41.80 | +31.58% | 19 | Sep 2, 2025 | |
| AARD Aardvark Therapeutics | Maintains: Outperform | $20 → $19 | $10.95 | +73.52% | 4 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $63 | $66.72 | -5.57% | 21 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $96 → $98 | $120.26 | -18.51% | 32 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $12 → $11 | $14.82 | -25.75% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $40 | $21.15 | +89.13% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $430 → $405 | $429.58 | -5.72% | 55 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $18 → $10 | $9.81 | +1.94% | 11 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $688 → $695 | $575.34 | +20.80% | 33 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $208 → $219 | $147.89 | +48.08% | 40 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $25 → $23 | $21.58 | +6.58% | 35 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $13 | $7.20 | +80.68% | 19 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $35 → $75 | $98.03 | -23.49% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $31 | $11.11 | +179.03% | 5 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $1.5 | $1.31 | +14.94% | 6 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $34 → $33 | $6.33 | +421.33% | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $58 | $17.90 | +224.02% | 8 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $84 | $31.68 | +165.15% | 1 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $31 | $12.75 | +143.14% | 1 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $1.79 | +67.60% | 13 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $4 | $2.25 | +77.78% | 6 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $139 → $143 | $127.88 | +11.82% | 2 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $35.92 | +11.36% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $22 | $12.40 | +77.42% | 9 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $25 → $15 | $10.94 | +37.11% | 14 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $12 → $9 | $5.59 | +61.00% | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $21 → $33 | $94.51 | -65.08% | 3 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $33.58 | - | 4 | Dec 4, 2017 |
Galapagos NV
Oct 22, 2025
Maintains: Sector Perform
Price Target: $27 → $28
Current: $32.60
Upside: -14.11%
MoonLake Immunotherapeutics
Sep 29, 2025
Downgrades: Sector Perform
Price Target: $67 → $10
Current: $9.34
Upside: +7.07%
Apogee Therapeutics
Sep 25, 2025
Initiates: Outperform
Price Target: $60
Current: $53.35
Upside: +12.46%
Incyte
Sep 24, 2025
Maintains: Sector Perform
Price Target: $72 → $81
Current: $88.00
Upside: -7.95%
aTyr Pharma
Sep 16, 2025
Downgrades: Sector Perform
Price Target: $16 → $1.5
Current: $0.97
Upside: +54.80%
Kymera Therapeutics
Sep 16, 2025
Initiates: Outperform
Price Target: $70
Current: $55.98
Upside: +25.04%
Neurocrine Biosciences
Sep 5, 2025
Maintains: Outperform
Price Target: $144 → $149
Current: $142.64
Upside: +4.46%
Sionna Therapeutics
Sep 3, 2025
Initiates: Sector Perform
Price Target: $22
Current: $39.51
Upside: -44.32%
Xenon Pharmaceuticals
Sep 2, 2025
Reiterates: Outperform
Price Target: $55
Current: $41.80
Upside: +31.58%
Aardvark Therapeutics
Aug 14, 2025
Maintains: Outperform
Price Target: $20 → $19
Current: $10.95
Upside: +73.52%
Aug 8, 2025
Maintains: Outperform
Price Target: $60 → $63
Current: $66.72
Upside: -5.57%
Aug 8, 2025
Maintains: Sector Perform
Price Target: $96 → $98
Current: $120.26
Upside: -18.51%
Aug 8, 2025
Maintains: Sector Perform
Price Target: $12 → $11
Current: $14.82
Upside: -25.75%
Aug 7, 2025
Maintains: Outperform
Price Target: $39 → $40
Current: $21.15
Upside: +89.13%
Aug 5, 2025
Maintains: Sector Perform
Price Target: $430 → $405
Current: $429.58
Upside: -5.72%
Aug 5, 2025
Maintains: Sector Perform
Price Target: $18 → $10
Current: $9.81
Upside: +1.94%
Aug 4, 2025
Maintains: Sector Perform
Price Target: $688 → $695
Current: $575.34
Upside: +20.80%
Aug 1, 2025
Maintains: Outperform
Price Target: $208 → $219
Current: $147.89
Upside: +48.08%
Jul 17, 2025
Maintains: Sector Perform
Price Target: $25 → $23
Current: $21.58
Upside: +6.58%
Jun 30, 2025
Reiterates: Outperform
Price Target: $13
Current: $7.20
Upside: +80.68%
Jun 24, 2025
Maintains: Outperform
Price Target: $35 → $75
Current: $98.03
Upside: -23.49%
May 15, 2025
Reiterates: Outperform
Price Target: $31
Current: $11.11
Upside: +179.03%
May 14, 2025
Reiterates: Sector Perform
Price Target: $1.5
Current: $1.31
Upside: +14.94%
May 13, 2025
Maintains: Outperform
Price Target: $34 → $33
Current: $6.33
Upside: +421.33%
May 7, 2025
Maintains: Outperform
Price Target: $65 → $58
Current: $17.90
Upside: +224.02%
Apr 22, 2025
Reiterates: Outperform
Price Target: $84
Current: $31.68
Upside: +165.15%
Mar 7, 2025
Initiates: Outperform
Price Target: $31
Current: $12.75
Upside: +143.14%
Mar 4, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $1.79
Upside: +67.60%
Mar 4, 2025
Reiterates: Sector Perform
Price Target: $4
Current: $2.25
Upside: +77.78%
Feb 3, 2025
Maintains: Outperform
Price Target: $139 → $143
Current: $127.88
Upside: +11.82%
Jan 28, 2025
Reiterates: Outperform
Price Target: $40
Current: $35.92
Upside: +11.36%
Jun 5, 2024
Reiterates: Outperform
Price Target: $22
Current: $12.40
Upside: +77.42%
Oct 2, 2023
Maintains: Sector Perform
Price Target: $25 → $15
Current: $10.94
Upside: +37.11%
Mar 31, 2022
Maintains: Sector Perform
Price Target: $12 → $9
Current: $5.59
Upside: +61.00%
Nov 3, 2021
Maintains: Sector Perform
Price Target: $21 → $33
Current: $94.51
Upside: -65.08%
Dec 4, 2017
Upgrades: Buy
Price Target: n/a
Current: $33.58
Upside: -